Cabometyx (cabozantinib)

pCPA File Number: 21238
Negotiation Status:
Concluded with an LOI
Indication(s):
For the treatment of Hepatocellular Carcinoma (HCC) in adults after prior therapy
Sponsor/Manufacturer:
Ipsen Biopharmaceuticals
CDA-AMC Project Number:
pCODR 10186
pCPA Engagement Letter Issued:
Negotiation Process Concluded: